Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations
Development of direct oral anticoagulants and their antidotes has led to the need to reconsider the eligibility of acute stroke patients who have been taking oral anticoagulants for intravenous thrombolysis. Officially authorized Japanese guidelines on this issue were revised twice at the time of ap...
Main Authors: | Kazunori Toyoda, Hiroshi Yamagami, Masatoshi Koga |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Stroke Society
2018-09-01
|
Series: | Journal of Stroke |
Subjects: | |
Online Access: | http://www.j-stroke.org/upload/pdf/jos-2018-01788.pdf |
Similar Items
-
Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
by: E. I. Baranova, et al.
Published: (2020-02-01) -
New oral anticoagulants and their reversal agents
by: Crista L. Laslo, et al.
Published: (2018-10-01) -
New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
by: E. I. Baranova
Published: (2018-11-01) -
The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation: Case reports
by: Tomić Milan
Published: (2020-01-01) -
Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report
by: Waldemar Kafke, et al.
Published: (2016-06-01)